Gapping down
In reaction to disappointing earnings/guidance: ENDP -30.3%, GST -26.3%,IMPV -18.8%, UNXL -17.4%, SQ -16.6%, BSQR -14.1%, FEYE -8.6%, (Chairman and CEO David DeWalt will assume executive chairman role; President Kevin Mandia will replace as CEO ), GPRO -7.7%, DATA -5.8%, CPA -5.8%, FLR-5.6%, CRC -4.8%, GDEN -4.2%, CERN -4.1%, OLED -3.7%, CYBR -3.3%, LOCO-3.3%, TRUE -3.2%, EFC -3.2%, PMT -2.3%, MT -2.1%, CTSH -2.1%, HRTX-1.9%, FPRX -1.9%, PETX -1.8%, LNG -1.7%, SPWR -1.5%, ICPT -1.5%, EGAN-1.4%, PDCE -1.4%, DEPO -1.3%, MDRX -1.2%, GERN -1.1%, LIND -0.8%
Select Chinese ADR's showing continued weakness: VNET -4.9%, AMCN -2.1%,YY -1.7%, YNDX -1.6%
Select oil/gas related names showing early weakness: SDRL -4.9%, CHK -2.8%,SSL -2.4%, STO -1.9%, RDS.A -1.4%, BP -1.3%, MRO -0.8%
Other news: KMPH -45.8% (the Anesthetic and Analgesic Drug Products Advisory Committee determined by a vote of 16 to 4 in that Apadaz should be approved for its proposed indication and voted 18 to 2 against inclusion of abuse deterrent labeling for the product), ARP -15.9% (suspends common unit and Class C preferred distributions, due to continued lower commodity price environment), PLG -8.8% (announces $33 mln bought-deal financing of 11 mln shares priced at $3.00/share with a syndicate of underwriters ), BANC -7% (announces 5.25 mln share underwritten public offering of common stock ),JCP -5.4% (NYPost detailed an internal memo on cost cutting measures amid recent sales decline), SO -4% (prices offering of 18.3 mln shares of common stock for gross proceeds of ~900 mln), VRX -3.3% ( announces formation of a new patient access & pricing committee responsible for pricing the co's drugs, chaired by CEO Joseph Papa), WBA -2.4% ( commences 15 mln common stock offering by selling stockholders), BHP -1.4% (provides Samarco update; Federal Court of Appeal in Brazil ratifies the agreement announced on Mar 2)
Analyst comments: ZTS -3.4% (downgraded to Sell from Neutral at Goldman),BNFT -1.6% (downgraded to Market Perform from Outperform at William Blair)
In reaction to disappointing earnings/guidance: ENDP -30.3%, GST -26.3%,IMPV -18.8%, UNXL -17.4%, SQ -16.6%, BSQR -14.1%, FEYE -8.6%, (Chairman and CEO David DeWalt will assume executive chairman role; President Kevin Mandia will replace as CEO ), GPRO -7.7%, DATA -5.8%, CPA -5.8%, FLR-5.6%, CRC -4.8%, GDEN -4.2%, CERN -4.1%, OLED -3.7%, CYBR -3.3%, LOCO-3.3%, TRUE -3.2%, EFC -3.2%, PMT -2.3%, MT -2.1%, CTSH -2.1%, HRTX-1.9%, FPRX -1.9%, PETX -1.8%, LNG -1.7%, SPWR -1.5%, ICPT -1.5%, EGAN-1.4%, PDCE -1.4%, DEPO -1.3%, MDRX -1.2%, GERN -1.1%, LIND -0.8%
Select Chinese ADR's showing continued weakness: VNET -4.9%, AMCN -2.1%,YY -1.7%, YNDX -1.6%
Select oil/gas related names showing early weakness: SDRL -4.9%, CHK -2.8%,SSL -2.4%, STO -1.9%, RDS.A -1.4%, BP -1.3%, MRO -0.8%
Other news: KMPH -45.8% (the Anesthetic and Analgesic Drug Products Advisory Committee determined by a vote of 16 to 4 in that Apadaz should be approved for its proposed indication and voted 18 to 2 against inclusion of abuse deterrent labeling for the product), ARP -15.9% (suspends common unit and Class C preferred distributions, due to continued lower commodity price environment), PLG -8.8% (announces $33 mln bought-deal financing of 11 mln shares priced at $3.00/share with a syndicate of underwriters ), BANC -7% (announces 5.25 mln share underwritten public offering of common stock ),JCP -5.4% (NYPost detailed an internal memo on cost cutting measures amid recent sales decline), SO -4% (prices offering of 18.3 mln shares of common stock for gross proceeds of ~900 mln), VRX -3.3% ( announces formation of a new patient access & pricing committee responsible for pricing the co's drugs, chaired by CEO Joseph Papa), WBA -2.4% ( commences 15 mln common stock offering by selling stockholders), BHP -1.4% (provides Samarco update; Federal Court of Appeal in Brazil ratifies the agreement announced on Mar 2)
Analyst comments: ZTS -3.4% (downgraded to Sell from Neutral at Goldman),BNFT -1.6% (downgraded to Market Perform from Outperform at William Blair)